R. John Fletcher
Known title: DirectorCIK: 0001215024
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 6, 2026
No recent news for KRMD. No new developments reported for KRMD in the past week.
Transaction History
| CLPT | ▲ Buy | Grant | 993 | $12K | 10/1/2026 | View on chart |
| KRMD | ▲ Buy | Grant | 7,679 | $22K | 10/1/2026 | View on chart |
| KRMD | ▲ Buy | Grant | 5,357 | $22K | 7/1/2026 | View on chart |
| CLPT | ▲ Buy | Grant | 662 | $12K | 7/1/2026 | View on chart |
| CLPT | ▲ Buy | Option Exercise | 12,417 | — | 5/19/2026 | View on chart |
| KRMD | ▲ Buy | Grant | 5,208 | $22K | 4/1/2026 | View on chart |
| CLPT | ▲ Buy | Grant | 1,270 | $12K | 4/1/2026 | View on chart |
| KRMD | ▲ Buy | Grant | 3,872 | $22K | 1/2/2026 | View on chart |
| CLPT | ▲ Buy | Grant | 422 | $6K | 1/2/2026 | View on chart |
| KRMD | ▲ Buy | Grant | 5,874 | $22K | 10/2/2025 | View on chart |
| CLPT | ▲ Buy | Grant | 265 | $6K | 10/1/2025 | View on chart |
| KRMD | ▲ Buy | Grant | 6,284 | $22K | 7/2/2025 | View on chart |
| CLPT | ▲ Buy | Grant | 484 | $6K | 7/1/2025 | View on chart |
| CLPT | ▲ Buy | Option Exercise | 21,093 | — | 5/16/2025 | View on chart |
| KRMD | ▲ Buy | Grant | 8,806 | $23K | 4/2/2025 | View on chart |
| CLPT | ▲ Buy | Grant | 486 | $6K | 4/1/2025 | View on chart |
| KRMD | ▲ Buy | Grant | 5,905 | $22K | 1/3/2025 | View on chart |
| CLPT | ▲ Buy | Grant | 375 | $6K | 1/2/2025 | View on chart |
| KRMD | ▲ Buy | Grant | 8,181 | $22K | 10/1/2024 | View on chart |
| CLPT | ▲ Buy | Grant | 515 | $6K | 10/1/2024 | View on chart |
| KRMD | ▲ Buy | Grant | 8,371 | $23K | 7/11/2024 | View on chart |
| CLPT | ▲ Buy | Grant | 1,072 | $6K | 7/1/2024 | View on chart |
| CLPT | ▲ Buy | Option Exercise | 17,153 | — | 5/14/2024 | View on chart |
| CLPT | ▲ Buy | Grant | 850 | $6K | 4/1/2024 | View on chart |
| KRMD | ▲ Buy | Grant | 9,493 | $22K | 3/31/2024 | View on chart |
| CLPT | ▲ Buy | Grant | 851 | $6K | 1/2/2024 | View on chart |
| KRMD | ▲ Buy | Grant | 9,493 | $22K | 12/31/2023 | View on chart |
| CLPT | ▲ Buy | Grant | 1,153 | $6K | 10/2/2023 | View on chart |
| KRMD | ▲ Buy | Grant | 8,226 | $23K | 9/30/2023 | View on chart |
| CLPT | ▲ Buy | Grant | 798 | $6K | 7/3/2023 | View on chart |
| KRMD | ▲ Buy | Grant | 6,465 | $22K | 6/30/2023 | View on chart |
| CLPT | ▲ Buy | Grant | 684 | $6K | 4/3/2023 | View on chart |
| KRMD | ▲ Buy | Grant | 5,281 | $22K | 3/31/2023 | View on chart |
| CLPT | ▲ Buy | Grant | 2,175 | $17K | 1/3/2023 | View on chart |
| KRMD | ▲ Buy | Grant | 6,410 | $22K | 12/31/2022 | View on chart |
| CLPT | ▲ Buy | Grant | 1,702 | $17K | 10/3/2022 | View on chart |
| KRMD | ▲ Buy | Grant | 10,022 | $23K | 9/30/2022 | View on chart |
| CLPT | ▲ Buy | Grant | 1,373 | $17K | 7/1/2022 | View on chart |
| KRMD | ▲ Buy | Grant | 9,003 | $23K | 6/30/2022 | View on chart |
| CLPT | ▲ Buy | Grant | 9,269 | $0 | 5/25/2022 | View on chart |
| CLPT | ▲ Buy | Grant | 1,741 | $17K | 4/1/2022 | View on chart |
| KRMD | ▲ Buy | Grant | 7,832 | $22K | 3/31/2022 | View on chart |
| CLPT | ▲ Buy | Grant | 2,003 | $23K | 1/1/2022 | View on chart |
| KRMD | ▲ Buy | Grant | 7,500 | $23K | 12/31/2021 | View on chart |
| CLPT | ▲ Buy | Grant | 1,290 | $23K | 10/1/2021 | View on chart |
| KRMD | ▲ Buy | Grant | 7,894 | $22K | 9/30/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 29, 2026
CLPT Featured in Pre-Market Movers
ClearPoint Neuro (CLPT) was highlighted in pre-market lists for Tuesday, indicating notable trading activity before the open. The stock is currently trading near its 52-week low of $8.27 and has shown a volume spike. While analyst targets remain significantly higher at an average of $23.50, the recent price action suggests heightened volatility and interest from traders.
CLPT Featured in Pre-Market Movers. ClearPoint Neuro (CLPT) was highlighted in pre-market lists for Tuesday, indicating notable trading activity before the open. The stock is currently trading near its 52-week low of $8.27 and has shown a volume spike. While analyst targets remain significantly higher at an average of $23.50, the recent price action suggests heightened volatility and interest from traders.